Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

November 28, 2023

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

Zoledronate or Alendronate

infusion (for zoledronate) or oral digestion (for alendronate)

Trial Locations (9)

11525

RECRUITING

251 Hellenic Airforce and VA General Hospital, Athens

11527

RECRUITING

First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens

14561

RECRUITING

, KAT General Hospital, Athens

53100

NOT_YET_RECRUITING

Department of Medicine, Surgery and Neurosciences, University of Siena, Siena

56429

RECRUITING

424 General Military Hospital, Thessaloniki

Unknown

RECRUITING

Univ. Lille, CHU Lille, Lille

NOT_YET_RECRUITING

Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Milan

NOT_YET_RECRUITING

University-Hospital S. Maria della Misericordia, Udine

00128

NOT_YET_RECRUITING

Campus Bio-Medico University, Roma

All Listed Sponsors
lead

424 General Military Hospital

OTHER